EP0672126A1 - Stabilized aqueous solutions of lipases - Google Patents

Stabilized aqueous solutions of lipases

Info

Publication number
EP0672126A1
EP0672126A1 EP93917567A EP93917567A EP0672126A1 EP 0672126 A1 EP0672126 A1 EP 0672126A1 EP 93917567 A EP93917567 A EP 93917567A EP 93917567 A EP93917567 A EP 93917567A EP 0672126 A1 EP0672126 A1 EP 0672126A1
Authority
EP
European Patent Office
Prior art keywords
lipase
derived
aqueous solution
cepacia
lipases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93917567A
Other languages
German (de)
English (en)
French (fr)
Inventor
Kim Borch
Shamkant Anant Patkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of EP0672126A1 publication Critical patent/EP0672126A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase

Definitions

  • This invention relates to the use of a water-soluble inorganic salt as stabilizing additive in aqueous solutions of lipases derived from a member of the genus Pseudomonas.
  • the invention provides a stabi ⁇ lized aqueous solution of lipases derived from members of the genus Pseudomonas, and a method of stabilizing lipases derived from members of the genus Pseudomonas in an aqueous solution.
  • the invention provides an aqueous solution comprising a lipase derived from a member of the genus Pseudomonas, said aqueous solution further comprising a stabilizing water-soluble divalent cation.
  • the invention provides a method of stabilizing a lipase derived from a member of the genus Pseudomonas in an aqueous solution, which method comprises incorporation of a water-soluble divalent cation.
  • the invention relates to the use of a stabilized aqueous solution of lipases derived from members of the genus Pseudomonas for use in processes for degreasing of hides and skins.
  • the invention relates to the use of a stabilized aqueous solution of lipases derived from members of the genus Pseudomonas for use in processes performed at elevated temperatures, e.g. for use in hydrolysis of water- insoluble esters, particularly triglycerides, in paper pulping processes.
  • the invention relates to the use of water-soluble inorganic salts as stabilizing additives in aqueous solutions of lipases derived from a member of the genus Pseudomonas.
  • lipases of other origin than Pseudomonas have been tested (i.e. lipases obtained from Humicola. Candida, and Rhizomucor) , but not found to be stabilized by the presence of calcium or magnesium ions.
  • lipases obtainable from members of the genus Pseudomonas were found to be stabilized.
  • the invention provides a stabilized aqueous solution of lipases derived from members of the genus Pseudomonas r said aqueous solution further comprising a stabilizing water-soluble divalent cation.
  • a lipase derived from a member of the genus Pseudomonas is understood as any lipase being obtainable from such a microorganism, including 5 mutants and variants thereof.
  • the lipase is derived from Ps. cepacia. Ps. aeru inosa, Ps. fracri. Ps. fluorescens. Ps. alcaliqenes. Ps. pseudoalcali enes. Ps. putida. or Ps. men- docina.
  • the lipase is derived from Ps. cepacia, Ps. fracri, Ps. alcaliqenes. Ps. pseudo- alcali enes. Ps. putida. or Ps. mendocina,, preferably Ps. cepacia.
  • the lipase is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoe
  • the invention can be applied whenever it is desired to stabilize a solution of a lipase derived from a member of the genus Pseudomonas, in order to maintain the lipolytic
  • the invention brings about stabilization of the lipase at any temperature of the activity interval of the enzyme. Therefore, the invention may be applied to a lipase solution intended for use at room temperature, or, particularly
  • the stabilizing water-soluble inorganic salt used in the invention contains a divalent cation, e.g. calcium or magnesium, preferably calcium.
  • a divalent cation e.g. calcium or magnesium
  • the concentration of the inorganic salt depends on i.a. the pH of the solution, the concentration of the lipase to be stabilized, and the required degree of stabilization.
  • the concentration of the inorganic salt should be at least stoechiometrically equivalent to the amount of lipase, i.e. at least a 1:1 molar ratio.
  • the concentration of the inorganic salt should be in the range of from at least a 1:1 molar ratio up to the solubi ⁇ lity limit in the system in question, depending on the required degree of stabilization.
  • concentration above 1 mM, particularly above 2 mM, is used for good stabilization.
  • concentration will usually be below 4 M, particularly below 2 M.
  • the invention also provides a method of stabilizing lipases derived from members of the genus Pseudomonas in an aqueous solution, which method comprises incorporation of a stabilizing water-soluble divalent cation.
  • the stabilizing water- soluble divalent cation is added in a concentration at least stochiometrically equivalent to the amount of lipase.
  • the stabilizing water-soluble divalent cation is calcium or magnesium, prefer ⁇ ably calcium.
  • the lipase to be stabilized is derived from Ps. cepacia. Ps. aeruginosa. Ps. fraqi. Ps. fluorescens, Ps. alcaliqenes. Ps. pseudoalcaligenes. Ps. putida. or Ps. mendocina.
  • the lipase to be stabi ⁇ lized is derived from Ps. cepacia. Ps. fragi. Ps. alcaligenes. Ps. pseudoalcaligenes. Ps. putida , or Ps. mendocina. preferably Ps. cepacia.
  • the lipase is derived from the strain Ps. cepacia. DSM 3401, or a mutant or a variant thereof.
  • the invention relates to the use of a stabilized aqueous solution of lipases derived from members of the genus Pseudomonas for use in processes where it is desir ⁇ able to maintain the lipolytic activity of the enzyme for an extended period.
  • the stabilized aqueous solution of lipases derived from members of the genus Pseudo ⁇ monas may be used in processes for degreasing hides and skins.
  • the stabilized solution of lipases derived from members of the genus Pseudo ⁇ monas may be used in a process performed at elevated tempera- tures, e.g. for use in hydrolysis of water-insoluble esters, particularly triglycerides, in paper pulping processes.
  • the composition of Bullion-3 medium was as follows:
  • the medium was autoclaved at 121°C for 40 minutes.
  • the culture broth of these Bullion-3 shake flasks was used as a seed culture for inoculating two hundred 500 ml shake flasks, each with 200 ml of PL-1 medium.
  • composition of the PL-1 medium was as follows:
  • the medium was autoclaved at 121°C for 40 minutes.
  • the culture broth was centrif ged for 35 minutes at 4100 xg by means of a Beck an Model J-6 centrifuge.
  • the supernatant was concentrated by filtration (washed with approximately 1 volume of water) to 1.4 1 by a Pellicon ultrafiltration apparatus from Millipore with a 10.000 M cut off filter sheet.
  • the concentrate was freeze dried, and the yield was 56.2 g of powder with an enzyme activity of 21.500 LU/g.
  • the concentrate was suspended in water and applied on a hydrophobic XAD-8 resin matrix, and eluted with 60% (v/v) 96% ethanol.
  • ammonium acetate was added to a final concentration of 0.5 M.
  • the enzyme was applied on a ToyopearlTM- Butyl column and eluted with 0.05 M glycine buffer, pH 9.3.
  • One Lipase Unit is the amount of enzyme which, under standard conditions (i.e. at 30.0°C; pH 7.0; and tribu- tyrine substrate) liberates 1 ⁇ mol of titratable butyric acid per minute.
  • a folder AF 95/5 describing this analytical method is available upon request to Novo Nordisk A/S, Denmark.
  • Enzyme solutions containing approx. 1 mg/ml of the Ps. cepacia lipase obtained according to Ex. 1, and containing either 2 mM CaCl 2 or 2 mM ELTA (metal chelating agent) were prepared.
  • 35 30"C corresponds to a half life of approx. 1 hour.
  • the lipase is "perfectly stable" in the presence of the stabilizing inorganic salt, but becomes rapidly inactivated in the absence of this salt.
  • the thermal denaturation temperature, T d was determined by heating an enzyme solution at a constant programmed rate.
  • a Ps. cepacia lipase obtained according to Ex. 1 A Ps. fluorescens lipase (AMANO PTM) , purchased from AMANO, Japan, and a Ps. fragi lipase, also purchased from AMANO, Japan. Lipase concentrations of approx. 1 g/ml were employed, and a total volume of approx. 1.2 ml was used for each experiment.
  • Thla sheet waa received oith the International application when filed (to be checked by the receiving Office)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP93917567A 1992-08-07 1993-08-09 Stabilized aqueous solutions of lipases Withdrawn EP0672126A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK994/92 1992-08-07
DK99492A DK99492D0 (da) 1992-08-07 1992-08-07 Nyt enzym
PCT/DK1993/000257 WO1994003592A1 (en) 1992-08-07 1993-08-09 Stabilized aqueous solutions of lipases

Publications (1)

Publication Number Publication Date
EP0672126A1 true EP0672126A1 (en) 1995-09-20

Family

ID=8099826

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93917567A Withdrawn EP0672126A1 (en) 1992-08-07 1993-08-09 Stabilized aqueous solutions of lipases

Country Status (4)

Country Link
EP (1) EP0672126A1 (da)
JP (1) JPH08500013A (da)
DK (1) DK99492D0 (da)
WO (1) WO1994003592A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5772786A (en) * 1993-08-13 1998-06-30 The Procter & Gamble Company Detergent composition comprising lime soap dispersant and lipase enzymes
AU3924195A (en) * 1994-11-28 1996-06-19 Novo Nordisk A/S Enzymatic degreasing of skins and hides
US7368273B2 (en) 2002-03-22 2008-05-06 Kao Corporation Alkaline protease
WO2010126156A2 (en) 2009-04-30 2010-11-04 Kao Corporation Alkaline protease variants
EP2434556B1 (en) 2009-05-22 2016-11-23 National Institute for Materials Science Ferromagnetic tunnel junction structure and magnetoresistive element using same
DE102017104480A1 (de) * 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Wässrige Lösung von Burlulipase umfassend Kalziumionen
JP7425459B2 (ja) * 2019-10-11 2024-01-31 株式会社シノテスト 安定化されたhmgb1含有溶液

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS505271B1 (da) * 1970-04-24 1975-03-01
DE3200274A1 (de) * 1982-01-07 1983-07-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur stabilisierung waessriger loesungen von cholesterinesterase aus pseudomonaden

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9403592A1 *

Also Published As

Publication number Publication date
JPH08500013A (ja) 1996-01-09
WO1994003592A1 (en) 1994-02-17
DK99492D0 (da) 1992-08-07

Similar Documents

Publication Publication Date Title
US5454971A (en) Alkaline lipase, method for producing the same, microorganism producing the same and detergent composition containing alkaline lipase
CA2202553A1 (en) Lipase, microorganism producing same, method for preparing said lipase and uses thereof
JPH0440990B2 (da)
US5658793A (en) Pseudomonas aeruginosa and its use in a process for the biotechnological preparation of L-rhamnose
EP0672126A1 (en) Stabilized aqueous solutions of lipases
Emanuilova et al. Thermoalkalophilic lipase-producing Bacillus selected by continuous cultivation
US5063160A (en) Identification, characterization, and method of production of a novel microbial lipase
AU643758B2 (en) Novel esterase and process for preparing the same
JPH066069B2 (ja) (十)‐トランス‐シクロプロパンカルボン酸の製造方法
US4705752A (en) Process for the enzymatic hydrolysis of D-α-amino-acid amides
Murphy et al. A second polycaprolactone depolymerase from Fusarium, a lipase distinct from cutinase
US5846801A (en) Thermostable lipase isolated from Pseudomonas solanacearum
EP0192401A2 (en) Polypeptide product
EP0243167A1 (en) A novel microorganism, a novel esterase and method for preparing the same
JPH0638746A (ja) アルカリリパーゼ、それを生産する微生物およびアルカリリパーゼ含有洗剤組成物
Parhi et al. Production and characterization of biosurfactant from Halomonas sp. BRI3
US5968801A (en) Polyhydroxyalkanoate depolymerase and process for producing the same
JPH0755147B2 (ja) 新規リパ−ゼ
CHAPPE et al. Variation of lipolytic activity in the genus Acinetobacter
JP4236323B2 (ja) 新規なエステル分解酵素
US4717665A (en) Recovery of microbial lipase
JPH0515387A (ja) 細菌によるアルギン酸の分解法
WO1993010224A1 (en) A cholesterol esterase acting lipase from pseudomonas cepacia
CA1318622C (en) Heteropolysaccharide s-184
JPH05304949A (ja) シュードモナス エスピー s10−071株及び該微生物の生産するリパーゼ

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950307

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE DE DK ES FR GB IT NL

17Q First examination report despatched

Effective date: 19990318

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19990521